Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
A phase 3 randomized trial comparing a long-acting injectable risperidone formulation to olanzapine tablets in adults with schizophrenia or …
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Pharmacokinetics of Paliperidone in Volunteers With Normal or Impaired Liver Function [Phase 1]
Phase 1 pharmacokinetic study of paliperidone in volunteers with normal or impaired liver function to assess drug exposure and safety consid…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia [Phase 3]
A Phase 3 safety and tolerability study of paliperidone palmitate injected in the shoulder or buttock for schizophrenia, with the trial comp…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A 52-week, Open-label Extension Study Following a 6-week, Double-blind, Placebo- and Active- Controlled Study (R076477-SCH-303) to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia [Phase 3]
This is a 52-week open-label extension of a 6-week double-blind, placebo- and active-controlled Phase 3 study evaluating the long-term safet…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations [Phase 1]
Phase 1 pharmacokinetic study comparing paliperidone Extended-Release with risperidone Immediate-Release in adults with Schizophrenia or Sch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia [Phase 1]
This Phase 1 study compares tolerability of extended-release paliperidone (ER OROS) with immediate-release risperidone in adults with schizo…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of Plasma Concentrations, Metabolism and Excretion of 14C-paliperidone After a Single Oral Dose [Phase 1]
Phase 1 pharmacokinetic study evaluating plasma concentrations, metabolism, and excretion of 14C-labeled paliperidone after a single oral do…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Safety and Pharmacokinetic Study of ER OROS Paliperidone in Pediatric Patients With Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder [Phase 1]
This Phase 1 safety and pharmacokinetic study evaluated the extended-release osmotic-release (ER OROS) formulation of paliperidone in pediat…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations [Phase 1]
This completed Phase 1 pharmacokinetics and pharmacodynamics study evaluated paliperidone extended-release and immediate-release formulation…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia [Phase 3]
A Phase 3 study comparing the effectiveness and safety of flexibly varied doses of paliperidone palmitate with risperidone for schizophrenia…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Study Evaluating and Comparing Single Dose and Multiple Dose Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese and Caucasian Adults. [Phase 1]
Phase 1 pharmacokinetic study evaluating single-dose and multiple-dose regimens of ER OROS paliperidone in healthy Japanese and Caucasian ad…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations [Phase 1]
This Phase 1 pharmacokinetics/pharmacodynamics study evaluated paliperidone extended-release and immediate-release formulations under fastin…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: 24-Week Open Label Extension to a Randomized, 6-Week Double Blind, Placebo Controlled Study, to Evaluate the Safety and Tolerability of Flexible Doses of Extended Release OROS® Paliperidone in the Treatment of Geriatric Subjects With Schizophrenia [Phase 3]
A 24-week open-label extension to a randomized, double-blind, placebo-controlled Phase 3 trial assessing the safety and tolerability of flex…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia [Phase 3]
A Phase 3 clinical trial evaluating three fixed doses of paliperidone extended-release (ER) tablets in combination with olanzapine for schiz…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of Paliperidone Enantiomer Disposition With Different Formulations and the Bioavailability of Immediate- and Extended-release Paliperidone [Phase 1]
Phase 1 study evaluating how paliperidone enantiomers are distributed across formulations and comparing the bioavailability of immediate-rel…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A 52 Week Open Label Extension Trial Following the Recurrence Prevention Study R076477-SCH-301 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia. [Phase 3]
A 52-week open-label extension study of paliperidone ER in schizophrenia to assess long-term safety and tolerability after the recurrence pr…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Bioequivalence Study of 15 mg ER OROS Paliperidone [Phase 1]
Phase 1 bioequivalence study of 15 mg extended-release OROS paliperidone in schizophrenia has completed. Sponsored by Johnson & Johnson Phar…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With Schizophrenia [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of two fixed doses of paliperidone extended-release tablets in adults with schizophrenia …
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia. [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of galantamine hydrobromide for cognitive impairment in schizophrenia has completed. T…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: Safety and Efficacy of an Anti-Psychotic in Patients With Schizophrenia [Phase 2]
This Phase 2 clinical trial update reports the safety and efficacy outcomes of an antipsychotic studied in patients with schizophrenia, with…
-
CLINICAL_TRIALS trial_result · 2011-05-24Clinical Trial Update: A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone [Phase 1]
Phase 1 dose-proportionality study evaluating five tablet strengths of ER OROS paliperidone to characterize pharmacokinetics in schizophreni…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia [Phase 3]
A Phase 3 randomized, double-blind trial evaluating the efficacy and safety of extended-release paliperidone for acute schizophrenia has com…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER [Phase 1]
A Phase 1 study evaluating the effect of paroxetine on the pharmacokinetics of paliperidone ER in schizophrenia, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Safety and Tolerability Study of Drug to Treat Schizophrenia [Phase 2]
Phase 2 safety and tolerability trial results for a Sumitomo Pharma America, Inc. drug to treat schizophrenia have been posted.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients
The trial evaluated the safety and effectiveness of risperidone for acute psychosis in patients with schizophrenia or related disorders. The…